Osiris Therapeutics to Present at Eighth Annual JMP Securities Research Conference

Share this story with your network

COLUMBIA, Md.–(BUSINESS WIRE)–Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell therapeutic company focused on developing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today that C. Randal Mills, Ph.D., President and CEO, is scheduled to present at the Eighth Annual JMP Securities Research Conference at The Ritz-Carlton in San Francisco, CA on Wednesday, May 20, 2009 at 11:30 a.m. PT.

A live audio webcast of the presentation may be accessed through the Investors page of the Company’s website at www.Osiris.com. An audio replay of the webcast will be available for 30 days following the conference.

Leave a Comment

Your email address will not be published. Required fields are marked *

*